GSK plc Reports Share Transactions for July 2025
Ticker: GLAXF · Form: 6-K · Filed: Jul 30, 2025 · CIK: 1131399
| Field | Detail |
|---|---|
| Company | Gsk PLC (GLAXF) |
| Form Type | 6-K |
| Filed Date | Jul 30, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: share-transactions, disclosure, 6-K
TL;DR
GSK bought/sold its own shares in July 2025. Details in 6-K.
AI Summary
GSK plc announced on July 30, 2025, that it conducted transactions involving its own shares. The filing, a Form 6-K, details these share transactions for the month of July 2025. GSK plc is a pharmaceutical preparations company based in London.
Why It Matters
This filing provides transparency into GSK's activities concerning its own stock, which can be a factor for investors monitoring company financial health and capital allocation strategies.
Risk Assessment
Risk Level: low — The filing is a routine disclosure of share transactions and does not indicate any immediate financial distress or significant operational changes.
Key Players & Entities
- GSK plc (company) — Registrant
- July 2025 (date) — Reporting period for share transactions
- 79 New Oxford Street, London, WC1A 1DG (address) — Principal executive office
- 001-15170 (other) — Commission File Number
FAQ
What type of transactions did GSK plc conduct in its own shares during July 2025?
The filing indicates that GSK plc conducted 'Transaction in own shares' during the month of July 2025.
What is the filing type and reporting period?
The filing is a Form 6-K, reporting for the month of July 2025.
Where is GSK plc's principal executive office located?
GSK plc's principal executive office is located at 79 New Oxford Street, London, WC1A 1DG.
What is GSK plc's SIC code?
GSK plc's Standard Industrial Classification (SIC) code is 2834, Pharmaceutical Preparations.
Has GSK plc previously operated under different names?
Yes, GSK plc was formerly known as GSK PLC (name change on 20220516) and prior to that, GlaxoSmithKline PLC (name change on 20010105).
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on July 30, 2025 regarding GSK plc (GLAXF).